Pure Global

Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration (LIGHTSITE III) - Trial NCT04065490

Access comprehensive clinical trial information for NCT04065490 through Pure Global AI's free database. This phase not specified trial is sponsored by LumiThera, Inc. and is currently Not yet recruiting. The study focuses on Dry Age-related Macular Degeneration. Target enrollment is 96 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
Device Trial
NCT04065490
Not yet recruiting
Device Trial
device
Trial Details
ClinicalTrials.gov • NCT04065490
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration (LIGHTSITE III)
A Double-Masked, Randomized, Sham-Controlled, Parallel Group, Multi-Center Study to Assess the Safety and Efficacy of Photobiomodulation (PBM) in Subjects With Dry Age-Related Macular Degeneration (AMD) (LIGHTSITE III)

Study Focus

Valeda PBM treatment

Interventional

device

Sponsor & Location

LumiThera, Inc.

Beverly Hills,Palo Alto,Altamonte Springs,Hagerstown,Cherry Hill,New York,Durham,Chambersburg,McAllen,The Woodlands,Silverdale, United States of America

Timeline & Enrollment

N/A

Sep 01, 2019

Jun 01, 2022

96 participants

Primary Outcome

Best Corrected Visual Acuity

Summary

This LIGHTSITE III study is a double-masked, sham-controlled, parallel design, prospective
 multi-site study for the use of PBM as a treatment for visual impairment in subjects with dry
 AMD.

ICD-10 Classifications

Peripheral retinal degeneration
Corneal degeneration
Hereditary retinal dystrophy
Optic atrophy in diseases classified elsewhere
Disorders of choroid and retina

Data Source

ClinicalTrials.gov

NCT04065490

Device Trial